Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease.

about

Aclidinium bromide for stable chronic obstructive pulmonary disease Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?QVA149 (indacaterol/glycopyrronium fixed-dose combination): a review of its use in patients with chronic obstructive pulmonary disease.

P2860

Q24193506-6349D7C9-3385-40CB-946F-BC15D238269B Q30365242-FC308A26-524A-45B7-A02A-DD97880BE348 Q38194114-65E042CF-FCF3-476F-946E-FE9F9AAA464C

P2860

Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease.

Item

http://www.wikidata.org/entity/Q38112092

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Aclidinium bromide: an alterna ...... obstructive pulmonary disease.

@en

type

Item

label

Aclidinium bromide: an alterna ...... obstructive pulmonary disease.

@en

prefLabel

Aclidinium bromide: an alterna ...... obstructive pulmonary disease.

@en

P1476

Aclidinium bromide: an alterna ...... obstructive pulmonary disease.

@en

P2093

J Andrew Woods

http://www.w3.org/2001/XMLSchema#string

Kimberly L Nealy

http://www.w3.org/2001/XMLSchema#string

Robert W Barrons

http://www.w3.org/2001/XMLSchema#string

P2860

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.

The MCID of the transition dyspnea index is a total score of one unit.

Minimal clinically important differences in COPD lung function.

Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

P304

1017-1028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1S002

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23737515

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease.

about

P2860

P2860

Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921